Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.64 |
| ▸ | MAPT | P10636 | 1/20 | 0.64 |
| ▸ | DNM1 | Q05193 | 8/20 | 0.62 |
| ▸ | TSHR | P16473 | 3/20 | 0.62 |
| ▸ | MEN1 | O00255 | 2/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.62 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.62 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.56 |
| ▸ | CES2 | O00748 | 3/20 | 0.54 |
| ▸ | CES1 | P23141 | 3/20 | 0.54 |
| ▸ | PPARG | P37231 | 3/20 | 0.52 |
| ▸ | PPARD | Q03181 | 3/20 | 0.52 |
| ▸ | PPARA | Q07869 | 3/20 | 0.52 |
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.52 |
| ▸ | HDAC11 | Q96DB2 | 2/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.52 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.52 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.52 |
| ▸ | TLR2 | O60603 | 1/20 | 0.52 |
| ▸ | ESR1 | P03372 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17364016 | 1.00 | KMT2A (0.64) | KMT2AMAPTDNM1TSHRMEN1 | |
| SCHEMBL29537727 | 1.00 | KMT2A (0.64) | KMT2AMAPTDNM1TSHRMEN1 | |
| SCHEMBL1685053 | 1.00 | KMT2A (0.64) | KMT2AMAPTDNM1TSHRMEN1 | |
| SCHEMBL30725710 | 1.00 | KMT2A (0.64) | KMT2AMAPTDNM1TSHRMEN1 | |
| SCHEMBL10490497 | 1.00 | KMT2A (0.64) | KMT2AMAPTDNM1TSHRMEN1 | |
| SCHEMBL10490370 | 1.00 | KMT2A (0.64) | KMT2AMAPTDNM1TSHRMEN1 | |
| SCHEMBL30725711 | 1.00 | KMT2A (0.64) | KMT2AMAPTDNM1TSHRMEN1 | |
| SCHEMBL120065 | 0.95 | KMT2A (0.64) | KMT2AMAPTDNM1TSHRMEN1 | |
| SCHEMBL115968 | 0.95 | KMT2A (0.64) | KMT2AMAPTDNM1TSHRMEN1 | |
| SCHEMBL116743 | 0.95 | KMT2A (0.64) | KMT2AMAPTDNM1TSHRMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1250907-B1 | Dilatant compositions | KAO CORP (JP) | 2005-10-19 | — | — | EP | disclosed |
| US-6946138-B2 | Dilatant composition | KAO CORPORATION (JP) | 2005-09-20 | — | — | US | disclosed |
| US-20030077299-A1 | Dilatant composition | KAO CORPORATION (JP) | 2003-04-24 | — | — | US | disclosed |
| EP-1250907-A2 | Dilatant compositions | Kao Corporation (JP) | 2002-10-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030077299-A1 | Dilatant composition | SCD, SGMS2, CERS2 | KMT2A 3429/4885MAPT 2566/4885DNM1 475/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.